Alice Lu-Culligan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nervous System | 1 | 2020 | 554 | 0.580 |
Why?
|
| Fetus | 2 | 2022 | 1880 | 0.560 |
Why?
|
| Placenta | 4 | 2023 | 1699 | 0.430 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2021 | 2026 | 0.420 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1580 | 0.380 |
Why?
|
| Gene Products, env | 1 | 2022 | 263 | 0.200 |
Why?
|
| Pregnancy Proteins | 1 | 2022 | 229 | 0.190 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 253 | 0.180 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.160 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3135 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 738 | 0.160 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3242 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
| Pregnancy | 5 | 2023 | 29144 | 0.150 |
Why?
|
| Saliva | 1 | 2020 | 809 | 0.140 |
Why?
|
| RNA, Viral | 2 | 2020 | 2901 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4751 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3177 | 0.100 |
Why?
|
| Vaccination | 1 | 2022 | 3279 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13035 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7323 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 5709 | 0.060 |
Why?
|
| Models, Biological | 1 | 2020 | 9584 | 0.060 |
Why?
|
| Galectin 1 | 1 | 2023 | 131 | 0.050 |
Why?
|
| Female | 6 | 2023 | 380193 | 0.050 |
Why?
|
| Neurons | 1 | 2021 | 9340 | 0.050 |
Why?
|
| Abortion, Therapeutic | 1 | 2020 | 35 | 0.050 |
Why?
|
| Animals | 3 | 2022 | 168768 | 0.050 |
Why?
|
| RNA Probes | 1 | 2020 | 113 | 0.050 |
Why?
|
| Galectins | 1 | 2023 | 268 | 0.050 |
Why?
|
| Molecular Probe Techniques | 1 | 2020 | 119 | 0.040 |
Why?
|
| Abruptio Placentae | 1 | 2020 | 118 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 712 | 0.040 |
Why?
|
| Mice | 2 | 2022 | 81201 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 744366 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 732 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2020 | 667 | 0.040 |
Why?
|
| Pandemics | 3 | 2020 | 8385 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2020 | 694 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14723 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 701 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 2804 | 0.030 |
Why?
|
| Viral Load | 1 | 2020 | 3300 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 1200 | 0.020 |
Why?
|
| RNA | 1 | 2020 | 2749 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6542 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2023 | 25628 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18034 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213390 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 214052 | 0.000 |
Why?
|
| Male | 1 | 2021 | 350115 | 0.000 |
Why?
|